Dow Valuation
Is DOW1 * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of DOW1 * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: DOW1 * (MX$996.8) is trading below our estimate of fair value (MX$2219.47)
Significantly Below Fair Value: DOW1 * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for DOW1 *?
Other financial metrics that can be useful for relative valuation.
| What is DOW1 *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$36.24b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.2x |
| Enterprise Value/EBITDA | 9.6x |
| PEG Ratio | 1.1x |
Price to Earnings Ratio vs Peers
How does DOW1 *'s PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 20.1x | ||
ORBIA * Orbia Advance Corporation. de | 15.1x | 33.3% | Mex$37.2b |
CYDSASA A Cydsa. de | 5.5x | 12.9% | Mex$8.6b |
GMEXICO B Grupo México. de | 11.8x | 6.9% | Mex$827.6b |
CEMEX CPO CEMEX. de | 48x | 35.6% | Mex$178.7b |
DOW1 * Dow | 31.8x | 27.7% | Mex$37.1b |
Price-To-Earnings vs Peers: DOW1 * is expensive based on its Price-To-Earnings Ratio (31.8x) compared to the peer average (20.4x).
Price to Earnings Ratio vs Industry
How does DOW1 *'s PE Ratio compare vs other companies in the Global Chemicals Industry?
Price-To-Earnings vs Industry: DOW1 * is expensive based on its Price-To-Earnings Ratio (31.8x) compared to the Global Chemicals industry average (20.8x).
Price to Earnings Ratio vs Fair Ratio
What is DOW1 *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 31.8x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate DOW1 *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$996.80 | Mex$1,126.33 +13.0% | 8.4% | Mex$1,397.00 | Mex$1,008.95 | n/a | 20 |
| Sep ’25 | n/a | Mex$1,132.99 0% | 7.3% | Mex$1,379.13 | Mex$996.04 | n/a | 20 |
| Aug ’25 | n/a | Mex$1,087.18 0% | 6.4% | Mex$1,254.08 | Mex$959.00 | n/a | 20 |
| Jul ’25 | n/a | Mex$1,117.86 0% | 6.3% | Mex$1,244.09 | Mex$951.37 | n/a | 20 |
| Jun ’25 | n/a | Mex$1,038.09 0% | 6.1% | Mex$1,147.81 | Mex$877.73 | n/a | 20 |
| May ’25 | n/a | Mex$1,040.57 0% | 6.4% | Mex$1,157.36 | Mex$885.04 | n/a | 21 |
| Apr ’25 | Mex$951.00 | Mex$972.03 +2.2% | 7.9% | Mex$1,130.94 | Mex$864.84 | n/a | 20 |
| Mar ’25 | n/a | Mex$985.48 0% | 7.4% | Mex$1,160.49 | Mex$887.44 | n/a | 20 |
| Feb ’25 | n/a | Mex$995.37 0% | 7.3% | Mex$1,171.13 | Mex$895.57 | n/a | 20 |
| Jan ’25 | n/a | Mex$961.32 0% | 7.6% | Mex$1,184.59 | Mex$841.23 | n/a | 20 |
| Dec ’24 | n/a | Mex$974.40 0% | 7.8% | Mex$1,205.02 | Mex$855.74 | n/a | 20 |
| Nov ’24 | Mex$879.35 | Mex$1,024.50 +16.5% | 7.9% | Mex$1,264.14 | Mex$897.72 | n/a | 20 |
| Oct ’24 | n/a | Mex$965.10 0% | 9.6% | Mex$1,233.08 | Mex$804.93 | n/a | 21 |
| Sep ’24 | n/a | Mex$969.43 0% | 9.8% | Mex$1,231.03 | Mex$803.59 | n/a | 22 |
| Aug ’24 | n/a | Mex$948.23 0% | 9.6% | Mex$1,201.06 | Mex$784.03 | n/a | 23 |
| Jul ’24 | n/a | Mex$975.11 0% | 9.9% | Mex$1,229.56 | Mex$802.63 | n/a | 25 |
| Jun ’24 | n/a | Mex$1,027.77 0% | 10.5% | Mex$1,273.56 | Mex$831.35 | n/a | 24 |
| May ’24 | Mex$975.00 | Mex$1,052.39 +7.9% | 10.6% | Mex$1,299.28 | Mex$848.14 | n/a | 22 |
| Apr ’24 | n/a | Mex$1,072.41 0% | 12.1% | Mex$1,328.14 | Mex$811.64 | Mex$951.00 | 22 |
| Mar ’24 | n/a | Mex$1,111.80 0% | 13.1% | Mex$1,379.08 | Mex$747.00 | n/a | 22 |
| Feb ’24 | Mex$990.00 | Mex$1,063.01 +7.4% | 14.0% | Mex$1,355.72 | Mex$734.35 | n/a | 22 |
| Jan ’24 | n/a | Mex$1,017.77 0% | 14.6% | Mex$1,366.02 | Mex$772.10 | n/a | 22 |
| Dec ’23 | n/a | Mex$985.10 0% | 12.6% | Mex$1,281.79 | Mex$769.08 | n/a | 22 |
| Nov ’23 | n/a | Mex$985.10 0% | 12.6% | Mex$1,281.79 | Mex$769.08 | Mex$879.35 | 22 |
| Oct ’23 | n/a | Mex$1,094.69 0% | 12.8% | Mex$1,308.00 | Mex$885.41 | n/a | 20 |
| Sep ’23 | n/a | Mex$1,172.04 0% | 10.9% | Mex$1,421.83 | Mex$901.16 | n/a | 19 |
Analyst Forecast: Target price is less than 20% higher than the current share price.